MML INVESTORS SERVICES, LLC - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 307 filers reported holding LIGAND PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 1.69 and the average weighting 0.2%.

Quarter-by-quarter ownership
MML INVESTORS SERVICES, LLC ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2019$219,000
-2.7%
2,200
+23.0%
0.00%
+33.3%
Q1 2019$225,000
-7.4%
1,7890.0%0.00%
-25.0%
Q4 2018$243,000
-35.2%
1,789
+31.0%
0.00%
-33.3%
Q3 2018$375,000
+55.6%
1,366
+17.4%
0.01%
+20.0%
Q2 2018$241,000
-20.7%
1,164
-36.7%
0.01%
-16.7%
Q1 2018$304,0001,8390.01%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q2 2019
NameSharesValueWeighting ↓
KNOTT DAVID M 1,199,766$130,078,630,00035.65%
CARDINAL CAPITAL MANAGEMENT LLC /CT 852,053$92,380,0005.34%
OBERWEIS ASSET MANAGEMENT INC/ 101,127$10,964,0003.08%
Timpani Capital Management LLC 68,160$7,390,0003.00%
ASHFORD CAPITAL MANAGEMENT INC 103,420$11,213,0002.64%
First Light Asset Management, LLC 56,818$6,160,0002.58%
Conestoga Capital Advisors, LLC 286,162$31,026,0002.51%
OAK RIDGE INVESTMENTS LLC 955,599$103,606,0002.48%
RK Capital 127,983$13,876,0002.42%
Nichols Asset Management LLC 93,170$10,101,0002.20%
View complete list of LIGAND PHARMACEUTICALS INC shareholders